Altogether, these new findings about the roles attributed to α cells and glucagon in islet cell functioning and maintenance have spotted glucagon as a potential peptide to be used in a coordinated treatment of deranged carbohydrate metabolism associated with obesity and T2DM. The gene discussed is GCG; the disease is type 2 diabetes mellitus.